Pfizer's rheumatoid arthritis treatment, tofacitinib, has obtained approval in several additional countries globally, including Switzerland, Argentina, Kuwait, UAE and Russia for patients with inadequate response to current therapies. The ...
Pharmaceutical packaging has to be carried out for the purpose of the safety of the pharmaceutical preparations in order to keep them free from contamination, hinder microbial growth, and ensure product safety through the intended shelf ...
Tags: Pharmaceutical Packaging, Packaging Machinery, Packaging, Health
Pharmaceutical packaging requires high attention to detail due to the critical nature of the materials required to protect the active product throughout its shelf life. Types of packaging material and design can also be influenced by the ...
Tags: Pharmaceutical Packaging, Packaging, Packaging Machinery
The Japanese Ministry of Health, Labour and Welfare (MHLW) has cleared Roche's Avastin (bevacizumab) as a combination therapy and monotherapy to treat the aggressive form of brain cancer glioblastoma. The first new medicine that is ...
Tags: Glioblastoma Therapy, Medicine
Quick-Med Technologies, Inc. (OTCQB: QMDT), a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that it has been awarded a contract by the U.S. Department of Defense ...
Tags: Textile, Med Technologies, Scar Contracture
Aurobindo Pharma has gained final FDA approval for its generic Nevirapine tablets and oral suspension used for treating human immunodeficiency virus (HIV). The FDA approved Nevirapine tablets of 200mg strength and Nevirapine oral ...
Tags: Aurobindo Pharma, FDA, Nevirapine, HIV drug
Celgene International has obtained FDA priority review status for Abraxane (paclitaxel protein-bound particles for injectable suspension) supplemental new drug application (sNDA). The application covers the use of Abraxane and gemcitabine ...
Tags: Celgene sNDA, FDA Priority
Researchers from the Universities of Dundee, Glasgow and Strathclyde have been awarded pound 691,000 as part of the first wave of funding made available through Prostate Cancer UK’s ambitious new research strategy. A colossal pound ...
Tags: Universities of Dundee, Researchers, Prostate Cancer UK
GlaxoSmithKline (GSK) has submitted marketing authorisation application, to the European Medicines Agency, for trametinib (MEK) as monotherapy and dabrafenib (BRAF)/MEK combination therapy in metastatic melanoma. The application was ...
Tags: GSK, metastatic melanoma therapy, Medicines
The United States Patent and Trademark Office has issued a patent covering the methods of cancer treatment with Lorus Therapeutics' novel therapy, IL-17E. Treatment methods with IL-17E include single and combination therapy along with ...
Tags: IL-17E, Lorus Therapeutics, Cancer Therapy, US Patent
The European Commission (EC) has approved broader indication of Janssen-Cilag International's oral, once-daily medication Zytiga (abiraterone acetate). Licence extension includes the use of Zytiga as a combination therapy along with ...
Tags: Zytiga, Janssen Europe, medical
GlaxoSmithKline and Theravance have announced the MAA submission for Anoro in Europe for patients with chronic obstructive pulmonary disease (COPD). The COPD therapy, administered using the ELLIPTA inhaler, is a combination of GSK573719 ...
Tags: GlaxoSmithKline, COPD therapy, chronic obstructive pulmonary disease
Janssen Therapeutics has obtained accelerated approval from FDA for Sirturo (bedaquiline) tablets as part of combination therapy to treat adult patients with pulmonary multi-drug resistant tuberculosis (MDR-TB). The surrogate endpoint of ...
Tags: Janssen Therapeutics, accelerated approval, FDA, Sirturo tablets
Aurobindo Pharma has won the final FDA approval to manufacture and market its generic anti-Human Immunodeficiency Virus (HIV) drug, Abacavir Tablets USP 300mg. Abacavir, the generic version of ViiV Healthcare Company's Ziagen Tablets ...
Tags: Anti-HIV Drug, FDA Nod, Aurobindo, Medicine
Poxel has raised €13m ($17m) in a series B round financing to develop and confirm efficacy data of Imeglimin, a drug used to treat type 2 diabetes. Imeglimin is a new tetrahydrotriazine-containing class of oral anti- diabetics, the ...
Tags: Poxel, efficacy data of Imeglimin, drug, ype 2 diabetes